D. Pilnik Richard's most recent trade in DiaMedica Therapeutics Inc was a trade of 24,000 Voting Common Shares, no par value per share done at an average price of $2.1 . Disclosure was reported to the exchange on April 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.11 per share. | 07 Apr 2025 | 24,000 | 312,995 (2%) | 0% | 2.1 | 50,640 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 24,000 | 0 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | Grant, award, or other acquisition of securities at price $ 5.34 per share. | 02 Jan 2025 | 10,393 | 288,995 (2%) | 0% | 5.3 | 55,499 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 01 Jun 2024 | 36,065 | 36,065 | - | - | Stock Option (right to buy) | ||
| DiaMedica Therapeutics Inc | D. Pilnik Richard | Director | 02 Jan 2024 | 30,357 | 278,602 (1%) | 0% | 2.8 | 85,000 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 23 Jun 2023 | 38,363 | 248,245 (1%) | 0% | 3.9 | 149,999 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 01 Jun 2023 | 22,355 | 22,355 | - | - | Stock Option (right to buy) | ||
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 03 Jan 2023 | 55,555 | 209,882 (1%) | 0% | 1.5 | 84,999 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 05 Dec 2022 | 35,000 | 154,327 (1%) | 0% | 1.4 | 48,493 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 01 Jun 2022 | 18,510 | 18,510 | - | - | Stock Option (right to buy) | ||
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 03 Jan 2022 | 23,762 | 119,327 (0%) | 0% | 3.6 | 85,068 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 16 Aug 2021 | 12,500 | 95,565 (0%) | 0% | 3.3 | 41,033 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 16 Aug 2021 | 2,500 | 83,065 (0%) | 0% | 3.2 | 8,032 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 15 Jul 2021 | 13,150 | 13,150 | - | - | Stock Option (right to buy) | ||
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 01 Jan 2021 | 9,719 | 80,565 (0%) | 0% | 8.2 | 79,987 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 04 Dec 2020 | 5,000 | 70,846 (0%) | 0% | 5.2 | 26,200 | Voting Common Shares, no par value per share | |
| DiaMedica Therapeutics Inc | Richard D. Pilnik | Director | 04 Dec 2020 | 5,000 | 65,846 (0%) | 0% | 5.5 | 27,497 | Voting Common Shares, no par value per share |